These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 25043017)

  • 1. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms.
    Arranz L; Sánchez-Aguilera A; Martín-Pérez D; Isern J; Langa X; Tzankov A; Lundberg P; Muntión S; Tzeng YS; Lai DM; Schwaller J; Skoda RC; Méndez-Ferrer S
    Nature; 2014 Aug; 512(7512):78-81. PubMed ID: 25043017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.
    Méndez-Ferrer S; Michurina TV; Ferraro F; Mazloom AR; Macarthur BD; Lira SA; Scadden DT; Ma'ayan A; Enikolopov GN; Frenette PS
    Nature; 2010 Aug; 466(7308):829-34. PubMed ID: 20703299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood loses it when nerves go bad.
    Baryawno N; Scadden DT
    Cell Res; 2014 Oct; 24(10):1151-2. PubMed ID: 25070156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloproliferative neoplasm stem cells.
    Mead AJ; Mullally A
    Blood; 2017 Mar; 129(12):1607-1616. PubMed ID: 28159736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hematopoietic Niche in Myeloproliferative Neoplasms.
    Schmitt-Graeff AH; Nitschke R; Zeiser R
    Mediators Inflamm; 2015; 2015():347270. PubMed ID: 26696752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2-V617F-positive myeloproliferative neoplasms.
    Usart M; Stetka J; Luque Paz D; Hansen N; Kimmerlin Q; Almeida Fonseca T; Lock M; Kubovcakova L; Karjalainen R; Hao-Shen H; Börsch A; El Taher A; Schulz J; Leroux JC; Dirnhofer S; Skoda RC
    Blood; 2024 Jun; 143(24):2490-2503. PubMed ID: 38493481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function.
    Isern J; García-García A; Martín AM; Arranz L; Martín-Pérez D; Torroja C; Sánchez-Cabo F; Méndez-Ferrer S
    Elife; 2014 Sep; 3():e03696. PubMed ID: 25255216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F.
    Lundberg P; Takizawa H; Kubovcakova L; Guo G; Hao-Shen H; Dirnhofer S; Orkin SH; Manz MG; Skoda RC
    J Exp Med; 2014 Oct; 211(11):2213-30. PubMed ID: 25288396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK2
    Zhan H; Ma Y; Lin CH; Kaushansky K
    Leukemia; 2016 Dec; 30(12):2332-2341. PubMed ID: 27133820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of JAK1/2 inhibition on bone marrow stromal cells of myeloproliferative neoplasm (MPN) patients and healthy individuals.
    Zacharaki D; Ghazanfari R; Li H; Lim HC; Scheding S
    Eur J Haematol; 2018 Jul; 101(1):57-67. PubMed ID: 29645296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sympathomimetic agonist mirabegron did not lower
    Drexler B; Passweg JR; Tzankov A; Bigler M; Theocharides AP; Cantoni N; Keller P; Stussi G; Ruefer A; Benz R; Favre G; Lundberg P; Nienhold R; Fuhrer A; Biaggi C; Manz MG; Bargetzi M; Mendez-Ferrer S; Skoda RC;
    Haematologica; 2019 Apr; 104(4):710-716. PubMed ID: 30409796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK2
    Lin CH; Kaushansky K; Zhan H
    Blood Cells Mol Dis; 2016 Nov; 62():42-48. PubMed ID: 27865175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.
    Dong L; Yu WM; Zheng H; Loh ML; Bunting ST; Pauly M; Huang G; Zhou M; Broxmeyer HE; Scadden DT; Qu CK
    Nature; 2016 Nov; 539(7628):304-308. PubMed ID: 27783593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.
    Rai S; Zhang Y; Grockowiak E; Kimmerlin Q; Hansen N; Stoll CB; Usart M; Luque Paz D; Hao-Shen H; Zhu Y; Roux J; Bader MS; Dirnhofer S; Farady CJ; Schroeder T; Méndez-Ferrer S; Skoda RC
    Blood Adv; 2024 Mar; 8(5):1234-1249. PubMed ID: 38207211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hematopoietic Microenvironment in Myeloproliferative Neoplasms: The Interplay Between Nature (Stem Cells) and Nurture (the Niche).
    Zhan H; Kaushansky K
    Adv Exp Med Biol; 2020; 1273():135-145. PubMed ID: 33119879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche.
    Maryanovich M; Zahalka AH; Pierce H; Pinho S; Nakahara F; Asada N; Wei Q; Wang X; Ciero P; Xu J; Leftin A; Frenette PS
    Nat Med; 2018 Jun; 24(6):782-791. PubMed ID: 29736022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm.
    Rai S; Grockowiak E; Hansen N; Luque Paz D; Stoll CB; Hao-Shen H; Mild-Schneider G; Dirnhofer S; Farady CJ; Méndez-Ferrer S; Skoda RC
    Nat Commun; 2022 Sep; 13(1):5346. PubMed ID: 36100613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering a haematopoietic stem cell niche by revitalizing mesenchymal stromal cells.
    Nakahara F; Borger DK; Wei Q; Pinho S; Maryanovich M; Zahalka AH; Suzuki M; Cruz CD; Wang Z; Xu C; Boulais PE; Ma'ayan A; Greally JM; Frenette PS
    Nat Cell Biol; 2019 May; 21(5):560-567. PubMed ID: 30988422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche.
    Hanoun M; Zhang D; Mizoguchi T; Pinho S; Pierce H; Kunisaki Y; Lacombe J; Armstrong SA; Dührsen U; Frenette PS
    Cell Stem Cell; 2014 Sep; 15(3):365-375. PubMed ID: 25017722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK2V617F-dependent down regulation of SHP-1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of TGF-β.
    Aoun C; Maslah N; Ganesan S; Salomao N; Gendron R; Awan Toor S; Letort G; Gou P; Bonnamy M; Parietti V; Kiladjian JJ; Giraudier S; Cassinat B
    J Cell Mol Med; 2024 Oct; 28(20):e70138. PubMed ID: 39431551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.